1. CLARITHROMYCIN AS a "REPURPOSING DRUG" AGAINST LYMPHOMAS: SAFETY AND EFFICACY PROFILES IN 55 PATIENTS WITH EXTRANODAL MARGINAL ZONE LYMPHOMA (EMZL). (June 2017) Authors: Ferreri, A.J.; Cecchetti, C.; Kiesewetter, B.; Sassone, M.; Calimeri, T.; Perrone, S.; Ponzoni, M.; Raderer, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas. (8th March 2016) Authors: Gaudio, E.; Tarantelli, C.; Kwee, I.; Barassi, C.; Bernasconi, E.; Rinaldi, A.; Ponzoni, M.; Cascione, L.; Targa, A.; Stathis, A.; Goodstal, S.; Zucca, E.; Bertoni, F. Journal: Annals of oncology Issue: Volume 27:Number 6(2016:Jun.) Page Start: 1123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ETS1 PHOSPHORYLATION AT THR38 (PETS1) IS ASSOCIATED WITH CELL OF ORIGIN (COO), CELL CYCLE ACTIVATION, AND INFERIOR OUTCOME IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). (June 2017) Authors: Chung, E.Y.; Ponzoni, M.; Xu‐Monette, Z.Y.; Cascione, L.; Priebe, V.; Gaudio, E.; Wang, J.; Zhang, J.; Visco, C.; Bhagat, G.; Zucca, E.; Rossi, D.; Young, K.H.; Bertoni, F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ETS1 POSITIVELY REGULATES FAIM3 IN ACTIVATED B CELL‐LIKE (ABC) DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). (June 2017) Authors: Priebe, V.; Chung, E.Y.; Cascione, L.; Kwee, I.; Arribas, A.; Sartori, G.; Napoli, S.; Rinaldi, A.; Mensah, A.A.; Ponzoni, M.; Zucca, E.; Rossi, D.; Lenz, G.; Thome, M.; Bertoni, F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY. (12th June 2019) Authors: Ferrero, S.; Ladetto, M.; Beldjord, K.; Drandi, D.; Stelitano, C.; Bernard, S.; Castagnari, B.; Bouabdallah, K.; Cesaretti, M.; Alvarez, I.; Gressin, R.; Ponzoni, M.; Tripodo, C.; Traverse‐Glehen, A.; Baseggio, L.; Liberati, A.; Merli, M.; Tessoulin, B.; Patti, C.; Cabras, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. INTERFERON-γ INDUCES A DUAL AND ALTERNATIVE EARLY BIOLOGICAL RESPONSE IN NEUROBLASTOMA CELLS: DIFFERENTIATION AND APOPTOSIS. (November 1996) Authors: Montaldo, P. G.; Chiesa, V.; Bado, M.; Raffaghello, L.; Rozzo, C.; Ponzoni, M. Journal: Biochemical Society transactions Issue: Volume 24:Number 4(1996) Page Start: 551S Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. INTRALESIONAL RITUXIMAB SUPPLEMENTED WITH AUTOLOGOUS SERUM IN RELAPSED CD20+ INDOLENT LYMPHOMAS OF THE CONJUNCTIVA: ACTIVITY AND SAFETY RESULTS OF THE "IRIS" TRIAL. (12th June 2019) Authors: Ferreri, A.J.; Sassone, M.; Miserocchi, E.; Govi, S.; Cecchetti, C.; Corti, M.E.; Calimeri, T.; Perrone, S.; Mappa, S.; Ponzoni, M.; Modorati, G. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT). (12th June 2019) Authors: Ferreri, A.J.; Sassone, M.C.; Angelillo, P.; Zaja, F.; Re, A.; Spina, M.; Di Rocco, A.; Fabbri, A.; Stelitano, C.; Frezzato, M.; Rusconi, C.; Zambello, R.; Arcari, A.; Bertoldero, G.; De Lorenzo, D.; Volpetti, S.; Calimeri, T.; Perrone, S.; Cecchetti, C.; Ciceri, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MULTI‐OMICS LANDSCAPE OF SPLENIC MARGINAL ZONE LYMPHOMA (SMZL) ‐ INTERIM ANALYSIS OF IELSG46 STUDY. (12th June 2019) Authors: Bruscaggin, A.; Mollejo, M.; Tapia, G.; Gomes da Silva, M.; Novak, U.; Dietrich, S.; Ponzoni, M.; Rambaldi, A.; Corradini, P.; Vitolo, U.; Merli, M.; Tzankov, A.; Cogliatti, S.; Montalban, C.; Marasca, R.; de Leval, L.; Visco, C.; Baptista, M.J.; Tousseyn, T.; Facchetti, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P1397: CHRONICALLY REDUCED LEVELS OF THROMBOPOIETIN IMPAIR HEMATOPOIETIC STEM CELL FUNCTION AND MEGAKARYOCYTE BONE MARROW NICHE. (23rd June 2022) Authors: Aprile, A.; Storto, M.; Malara, A.; Gulino, A.; Raggi, L.; Sighinolfi, S.; Beretta, S.; Merelli, I.; Marktel, S.; Ponzoni, M.; Tripodo, C.; Balduini, A.; Ferrari, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗